All In Biotech

Free tool

FAERS Monitor: Restasis Multidose

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050790 or its brand name (Restasis Multidose, Cyclosporine). Reports on generic versions are filed under their own applications.

Reports

91,100

Serious

60,662

67% of reports

Hospitalization

20,597

Death reported

11,654

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective11,507
  • off label use9,378
  • eye irritation6,681
  • product use in unapproved indication3,873
  • eye pain3,413
  • nausea3,174
  • headache3,156
  • diarrhoea3,140
  • pyrexia3,112
  • fatigue3,078
  • vision blurred2,697
  • pain2,657
  • condition aggravated2,656
  • pneumonia2,458
  • pruritus2,331

Reports by year received

View as table
YearReports
2004908
2005937
20061,072
20071,048
20081,793
20092,070
20102,639
20113,374
20122,715
20131,991
20142,616
20153,248
20164,300
20174,465
20184,346
20195,384
20205,813
20215,698
20227,320
20237,509
20248,330
20257,700
20265,818

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,963,059 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
eye irritationSignal6,68130.229.4167,084
eye painSignal3,41314.814.341,362
vision blurredSignal2,6974.64.47,509
product use in unapproved indicationSignal3,8733.63.57,417
off label useSignal9,3782.52.48,619
pyrexiaSignal3,1122.12.01,772
condition aggravatedSignal2,6562.02.01,387
drug ineffectiveSignal11,5072.02.06,310
pneumonia2,4581.81.7810
pruritus2,3311.41.3273
headache3,1561.21.174
diarrhoea3,1401.11.144
pain2,6571.01.00
nausea3,1740.90.920
fatigue3,0780.90.927

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.